Clinical Trials Directory

Trials / Completed

CompletedNCT01685567

Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure

INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
219 (actual)
Sponsor
Silk Road Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to obtain and establish the safety and efficacy of The MICHI™ Neuroprotection System with Filter (MICHI™ NPS+f) for providing cerebral embolic protection during angioplasty and stenting procedures in carotid arteries. The MICHI NPS+f also facilitates access to the carotid and neuro anatomy for the introduction of therapeutic or diagnostic endovascular devices and/or agents. It will be used in conjunction with a FDA approved carotid artery stent for the treatment of carotid artery disease.

Detailed description

Cerebral embolization during carotid artery stenting (CAS) can often precipitate severe adverse neurological effects. Most major clinical studies of CAS have used distal filters for cerebral protection and have compared the neurologic complication rates with those of carotid endarterectomy (CEA). Many currently available embolic protection devices, however, have limited efficacy in capturing microembolic debris that is liberated during stenting, pre-dilatation and post-dilatation. Distal protection systems are furthermore limited by the need to cross the lesion prior to deployment. Some studies have shown a relatively high incidence of cerebral infarction even when distal protection devices are employed. Cerebral protection with carotid flow reversal is a method that was developed as an alternative to the use of distal protection devices. While novel in its approach, this method too has its limitations. Another technique developed employs carotid flow reversal prior to traversing the stenosis and can be accomplished by directly accessing the carotid anatomy without the use of the transfemoral approach. Major benefits to this method include a simpler route to the target lesion and the ability to perform the procedure on patients with severe carotid tortuosity and difficult aortic arch anatomy.

Conditions

Interventions

TypeNameDescription
DEVICEMICHI NPS+fCerebral protection with carotid flow reversal

Timeline

Start date
2012-11-01
Primary completion
2016-03-01
Completion
2016-07-01
First posted
2012-09-14
Last updated
2017-07-07
Results posted
2017-03-06

Locations

21 sites across 2 countries: United States, Spain

Source: ClinicalTrials.gov record NCT01685567. Inclusion in this directory is not an endorsement.